Profile data is unavailable for this security.
About the company
Annexin Pharmaceuticals AB (publ) is a Sweden-based biotechnology company. Its main product is ANXV, a human recombinant protein Annexin A5, for emergency treatment of patients with cardiovascular disease with blood vessel damages and inflammation. ANXV has the ability to protect and repair the blood vessels, as well as counteract the inflammation. In addition, the Company has a comprehensive patent portfolio for the treatment of diseases that occur because of damage and blood vessel inflammation. The production process is patented. The Company maintains a cell line for manufacture of Annexin A5. The Company’s main shareholders are Mikael Loenn, Frostskog AB, Medirista AB and Colinex Capital AB.
- Revenue in SEK (TTM)0.00
- Net income in SEK-46.41m
- Incorporated2014
- Employees4.00
- LocationAnnexin Pharmaceuticals AB (publ)Drottninggatan 65STOCKHOLM 111 36SwedenSWE
- Websitehttps://www.annexinpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Works Technologies AB | 43.90m | -56.82m | 108.75m | 38.00 | -- | 2.47 | -- | 2.48 | -1.58 | -1.58 | 1.22 | 1.13 | 0.571 | 1.82 | 5.83 | 1,155,158.00 | -73.91 | -49.14 | -101.72 | -57.90 | 61.10 | 69.88 | -129.44 | -168.30 | 2.79 | -- | 0.00 | -- | 6.23 | 46.24 | -26.41 | -- | 1.95 | -- |
| Isofol Medical AB (publ) | 0.00 | -31.16m | 112.90m | 4.00 | -- | 0.9995 | -- | -- | -0.1964 | -0.1964 | 0.00 | 0.6993 | 0.00 | -- | -- | 0.00 | -20.49 | -66.73 | -24.10 | -88.27 | -- | -- | -- | -1,023.62 | -- | -- | 0.00 | -- | -94.37 | -- | 76.80 | -- | -- | -- |
| Odi Pharma AB (publ) | 818.38k | -3.97m | 117.19m | -- | -- | 57.55 | -- | 143.20 | -0.2608 | -0.2608 | 0.0538 | 0.1338 | 0.1084 | 1.22 | 6.98 | -- | -52.58 | -- | -95.24 | -- | -53.07 | -- | -484.96 | -- | 1.32 | -14.10 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
| Biovica International AB | 5.98m | -122.99m | 119.48m | 37.00 | -- | 0.9491 | -- | 19.99 | -2.42 | -2.42 | 0.115 | 1.62 | 0.033 | -0.3053 | 8.43 | 170,800.00 | -67.80 | -42.10 | -74.69 | -46.33 | 110.09 | 277.88 | -2,057.41 | -2,149.68 | 7.10 | -- | 0.057 | -- | 65.43 | 4.44 | -84.14 | -- | -20.20 | -- |
| New Nordic Healthbrands AB | 537.81m | -10.17m | 120.19m | 70.00 | -- | 1.15 | -- | 0.2235 | -1.64 | -1.64 | 86.81 | 16.86 | 2.16 | 1.84 | 4.96 | 7,367,219.00 | -4.09 | 5.36 | -9.16 | 10.55 | 65.32 | 67.30 | -1.89 | 2.38 | 0.8584 | -4.44 | 0.2821 | 47.96 | 9.51 | 6.28 | -119.41 | -- | 28.36 | -- |
| Bactiquant A/S | 19.27m | -20.53m | 122.57m | -- | -- | 5.43 | -- | 6.36 | -0.6358 | -0.6358 | 0.5971 | 0.6133 | 0.5055 | 3.67 | 2.83 | -- | -53.83 | -41.26 | -62.59 | -47.16 | -6.14 | 12.89 | -106.51 | -71.77 | 5.43 | -8.54 | 0.0431 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
| Circa Group AS | 19.62m | -69.84m | 124.25m | 17.00 | -- | 0.335 | -- | 6.33 | -0.6089 | -0.6089 | 0.1712 | 3.04 | 0.042 | -- | 0.9812 | 1,155,391.00 | -14.94 | -- | -18.01 | -- | 80.23 | -- | -355.99 | -- | 1.99 | -- | 0.00 | -- | 41.73 | -- | -0.0491 | -- | -- | -- |
| Xintela AB | 78.00k | -54.09m | 141.18m | -- | -- | 32.23 | -- | 1,810.06 | -0.1524 | -0.1524 | 0.0002 | 0.0077 | 0.0036 | -- | 0.0088 | -- | -252.09 | -181.06 | -1,065.04 | -391.61 | 100.00 | -- | -69,343.59 | -235,894.00 | -- | -50.47 | 0.00 | -- | -- | -45.54 | 18.32 | -- | -61.47 | -- |
| StenoCare A/S | 5.89m | -27.52m | 144.57m | 9.00 | -- | 3.53 | -- | 24.56 | -1.29 | -1.29 | 0.271 | 1.42 | 0.0967 | -- | 1.25 | 417,535.60 | -45.21 | -28.15 | -63.19 | -35.47 | -- | -- | -467.55 | -371.06 | 1.30 | -5.54 | 0.2727 | -- | -16.30 | -- | -7.77 | -- | -- | -- |
| Vo2 Cap Holding AB (publ) | 342.81m | 3.21m | 152.96m | 103.00 | 47.15 | 0.6917 | 3.00 | 0.4462 | 0.0607 | 0.0607 | 6.50 | 4.13 | 0.7493 | -- | 7.03 | 3,328,282.00 | 0.7023 | -0.2564 | 0.9347 | -0.3839 | 34.62 | 23.36 | 0.9373 | -0.2409 | -- | 1.18 | 0.1564 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -46.41m | 154.35m | 4.00 | -- | 17.11 | -- | -- | -0.1765 | -0.1765 | 0.00 | 0.0171 | 0.00 | -- | -- | 0.00 | -256.08 | -125.42 | -351.79 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Vivesto AB | 0.00 | -128.74m | 161.41m | 14.00 | -- | 0.8161 | -- | -- | -0.2414 | -0.2414 | 0.00 | 0.3676 | 0.00 | -- | -- | 0.00 | -44.66 | -- | -48.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | 64.80 | -- | -- | -- |
| AlzeCure Pharma AB | 0.00 | -37.43m | 165.77m | 11.00 | -- | 8.39 | -- | -- | -0.5685 | -0.5685 | 0.00 | 0.2122 | 0.00 | -- | -- | 0.00 | -92.80 | -52.78 | -115.25 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
| PMD Device Solutions AB | 28.62m | -36.18m | 169.92m | 1.00 | -- | -- | -- | 5.94 | -16.69 | -16.69 | 6.34 | -4.79 | 0.9465 | -- | 57.42 | -- | -119.63 | -- | -- | -- | 58.18 | -- | -126.39 | -- | 0.0505 | -3.00 | -- | -- | -- | -- | -- | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -45.80m | 184.13m | 11.00 | -- | 6.00 | -- | -- | -0.172 | -0.172 | 0.00 | 0.0848 | 0.00 | -- | -- | -- | -96.37 | -57.97 | -126.15 | -97.83 | -- | -- | -- | -1,454.61 | -- | -- | 0.1291 | -- | -- | -- | 21.54 | -- | -- | -- |
| Enorama Pharma AB | 1.36m | -44.61m | 192.82m | 5.00 | -- | 9.05 | -- | 141.98 | -1.16 | -1.16 | 0.0353 | 0.3858 | 0.0327 | 1.48 | 1.38 | 271,600.00 | -107.36 | -73.56 | -147.57 | -104.85 | -287.26 | 43.36 | -3,285.20 | -557.42 | 0.8487 | -16.95 | 0.0218 | -- | -80.17 | -23.71 | -6.15 | -- | -- | -- |
Data as of May 15 2024. Currency figures normalised to Annexin Pharmaceuticals AB (publ)'s reporting currency: Swedish Krona SEK
